Targets for pancreatic cancer chemotherapy. Medical search. Frequent questions

Home page Questions and answers Statistics Donations Contact

Anatomy8

Cell Line, Tumor Tumor Cells, Cultured Pancreas Neoplastic Stem Cells Pancreatic Ducts Pancreatic Stellate Cells KB Cells Cell Line

Organisms3

Mice, Nude Mice, Inbred BALB C Mice, SCID

Diseases52

Pancreatic Neoplasms Neoplasms Carcinoma, Pancreatic Ductal Breast Neoplasms Adenocarcinoma Lung Neoplasms Vomiting Nausea Neoplasm Metastasis Ovarian Neoplasms Colonic Neoplasms Neoplasm Invasiveness Stomach Neoplasms Carcinoma Colorectal Neoplasms Neoplasm Recurrence, Local Disease Progression Prostatic Neoplasms Neutropenia Liver Neoplasms Carcinoma, Non-Small-Cell Lung Vomiting, Anticipatory Carcinoma, Squamous Cell Pancreatitis Genetic Predisposition to Disease Neoplasms, Experimental Peritoneal Neoplasms Mucositis Pancreatitis, Chronic Fatigue Pregnancy Complications, Neoplastic Testicular Neoplasms Bone Neoplasms Lymphoma Neovascularization, Pathologic Urinary Bladder Neoplasms Cell Transformation, Neoplastic Uterine Cervical Neoplasms Rectal Neoplasms Disease Models, Animal Esophageal Neoplasms Head and Neck Neoplasms Brain Neoplasms Lymphoma, Non-Hodgkin Gastrointestinal Neoplasms Hodgkin Disease Neoplasms, Second Primary Fever Lymphatic Metastasis Neoplasms, Germ Cell and Embryonal Recurrence Neoplasms, Glandular and Epithelial

Chemicals and Drugs76

Antineoplastic Agents Deoxycytidine Cisplatin Doxorubicin Antimetabolites, Antineoplastic Cyclophosphamide Antineoplastic Agents, Phytogenic Paclitaxel Etoposide Antiemetics Tumor Markers, Biological Antibiotics, Antineoplastic Vinblastine Methotrexate Taxoids CA-19-9 Antigen Organoplatinum Compounds Fluorouracil Neoplasm Proteins Antineoplastic Agents, Alkylating Camptothecin Anthracyclines P-Glycoprotein Mitomycin RNA, Messenger Prodrugs RNA, Small Interfering Carboplatin Daunorubicin Drug Carriers DNA, Neoplasm Tumor Suppressor Protein p53 Platinum Cytarabine Aniline Mustard Adjuvants, Pharmaceutic Mitoxantrone Enzyme Inhibitors Cancer Vaccines Mitomycins Antibodies, Monoclonal Receptor, erbB-2 Peptichemio Protein Kinase Inhibitors Granulocyte Colony-Stimulating Factor Bleomycin Antibodies, Monoclonal, Humanized Receptors, Estrogen Ifosfamide Antigens, Neoplasm Tegafur DNA-Binding Proteins Multidrug Resistance-Associated Proteins Receptor, Epidermal Growth Factor Indoles Quinazolines Proto-Oncogene Proteins c-bcl-2 Oxonic Acid Topoisomerase II Inhibitors Recombinant Proteins Tamoxifen Thymidylate Synthase Metoclopramide Proto-Oncogene Proteins Carcinoembryonic Antigen Antigens, Tumor-Associated, Carbohydrate MicroRNAs Polyethylene Glycols Antineoplastic Agents, Hormonal ATP-Binding Cassette Transporters Smad4 Protein Platinum Compounds Receptors, Progesterone ras Proteins Protein-Serine-Threonine Kinases RNA, Neoplasm

Analytical, Diagnostic and Therapeutic Techniques and Equipment74

Antineoplastic Combined Chemotherapy Protocols Chemotherapy, Adjuvant Combined Modality Therapy Treatment Outcome Prognosis Survival Analysis Xenograft Model Antitumor Assays Survival Rate Neoplasm Staging Disease-Free Survival Drug Screening Assays, Antitumor Drug Administration Schedule Early Detection of Cancer Clinical Trials as Topic Neoplasm Transplantation Neoadjuvant Therapy Drug Delivery Systems Prospective Studies Follow-Up Studies Transplantation, Heterologous Blotting, Western Reverse Transcriptase Polymerase Chain Reaction Molecular Targeted Therapy Kaplan-Meier Estimate Drug Therapy Immunohistochemistry Risk Factors Palliative Care Drug Carriers Tumor Burden Radiotherapy, Adjuvant Radiotherapy Gene Expression Profiling Transfection Induction Chemotherapy Multivariate Analysis Pancreatectomy Inhibitory Concentration 50 Flow Cytometry Retrospective Studies Neoplasms, Experimental Risk Risk Assessment Drug Evaluation Chemotherapy, Cancer, Regional Perfusion Models, Biological Administration, Oral Salvage Therapy Odds Ratio Sensitivity and Specificity Predictive Value of Tests Drug Evaluation, Preclinical Radiotherapy Dosage Registries Infusions, Intravenous Disease Models, Animal Drug Design Oligonucleotide Array Sequence Analysis Random Allocation Tomography, X-Ray Computed Chemoradiotherapy Cohort Studies SEER Program Polymerase Chain Reaction Incidence Pancreaticoduodenectomy Immunoenzyme Techniques Transplantation, Autologous Gene Knockdown Techniques Tissue Array Analysis Feasibility Studies Clinical Trials, Phase III as Topic Immunotherapy Questionnaires

Psychiatry and Psychology1

Phenomena and Processes37

Drug Resistance, Neoplasm Gene Expression Regulation, Neoplastic Drug Resistance, Multiple Apoptosis Cell Proliferation Dose-Response Relationship, Drug Cell Survival Drug Synergism Time Factors Signal Transduction Cell Cycle Mutation Cell Division Down-Regulation Transfection Inhibitory Concentration 50 Genetic Predisposition to Disease DNA Damage Cell Growth Processes Risk Cell Movement Genes, MDR Drug Resistance DNA Repair RNA Interference Odds Ratio Sensitivity and Specificity Gene Expression Genes, ras Phosphorylation Up-Regulation Gene Silencing DNA Methylation Cell Death Genotype Epithelial-Mesenchymal Transition Base Sequence

Disciplines and Occupations3

Immunohistochemistry Medical Oncology Drug Design

Anthropology, Education, Sociology and Social Phenomena2

Quality of Life National Cancer Institute (U.S.)

Technology, Industry, Agriculture2

Nanoparticles Polyethylene Glycols

Humanities1

Quality of Life

Information Science7

Survival Rate Registries SEER Program Incidence Base Sequence Molecular Sequence Data Questionnaires

Named Groups1

Health Care27

Treatment Outcome Survival Analysis Survival Rate Disease-Free Survival Clinical Trials as Topic Prospective Studies Follow-Up Studies Kaplan-Meier Estimate Risk Factors Palliative Care Multivariate Analysis Retrospective Studies Risk Risk Assessment Age Factors Odds Ratio Sensitivity and Specificity Predictive Value of Tests Registries Random Allocation Cohort Studies SEER Program Incidence Feasibility Studies Clinical Trials, Phase III as Topic National Cancer Institute (U.S.)Questionnaires

Geographicals2

United States Japan

Anatomy Organisms Diseases Chemicals and Drugs Analytical, Diagnostic and Therapeutic Techniques and Equipment Psychiatry and Psychology Phenomena and Processes Disciplines and Occupations Anthropology, Education, Sociology and Social Phenomena Technology, Industry, Agriculture Humanities Information Science Named Groups Health Care Geographicals

Pancreatic Neoplasms Antineoplastic Combined Chemotherapy Protocols Antineoplastic Agents Chemotherapy, Adjuvant Neoplasms Carcinoma, Pancreatic Ductal Cell Line, Tumor Deoxycytidine Cisplatin Drug Resistance, Neoplasm Doxorubicin Combined Modality Therapy Antimetabolites, Antineoplastic Breast Neoplasms Adenocarcinoma Lung Neoplasms Mice, Nude Cyclophosphamide Treatment Outcome Vomiting Antineoplastic Agents, Phytogenic Prognosis Gene Expression Regulation, Neoplastic Nausea Neoplasm Metastasis Drug Resistance, Multiple Paclitaxel Survival Analysis Xenograft Model Antitumor Assays Apoptosis Survival Rate Ovarian Neoplasms Neoplasm Staging Etoposide Disease-Free Survival Antiemetics Tumor Markers, Biological Antibiotics, Antineoplastic Cell Proliferation Tumor Cells, Cultured Drug Screening Assays, Antitumor Drug Administration Schedule Colonic Neoplasms Neoplasm Invasiveness Early Detection of Cancer Vinblastine Methotrexate Clinical Trials as Topic Dose-Response Relationship, Drug Cell Survival Taxoids Neoplasm Transplantation Stomach Neoplasms CA-19-9 Antigen Organoplatinum Compounds Fluorouracil Neoplasm Proteins Antineoplastic Agents, Alkylating Neoadjuvant Therapy Carcinoma Drug Delivery Systems Prospective Studies Drug Synergism Camptothecin Colorectal Neoplasms Time Factors Neoplasm Recurrence, Local Disease Progression Prostatic Neoplasms Follow-Up Studies Anthracyclines P-Glycoprotein Mitomycin Neutropenia RNA, Messenger Prodrugs Liver Neoplasms Transplantation, Heterologous Carcinoma, Non-Small-Cell Lung Blotting, Western Reverse Transcriptase Polymerase Chain Reaction RNA, Small Interfering Pancreas Molecular Targeted Therapy Signal Transduction Kaplan-Meier Estimate Carboplatin Drug Therapy Cell Cycle Immunohistochemistry Daunorubicin Risk Factors Mutation Palliative Care Vomiting, Anticipatory Drug Carriers DNA, Neoplasm Tumor Suppressor Protein p53 Tumor Burden Platinum

No FAQ available that match "targets for pancreatic cancer chemotherapy"